Evidence map›Paper›PMID 40832376›Full record

ArticlemedRxiv : the preprint server for health sciences2025

THE IMPACT OF NATIONAL CONTEXT ON COVID-19 VACCINE HESITANCY ACROSS EUROPE: A MULTI-LEVEL APPROACH.

Michael Bergmann, Arne Bethmann, Tessa-Virginia Hannemann, Alexander Schumacher, Nikolaos Theodoropoulos

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Michael BergmannSHARE Survey Methodology, SHARE Berlin Institute, Germany.ORCID 0000-0002-1905-8638
Arne BethmannSHARE Germany, SHARE Berlin Institute.ORCID 0000-0002-7649-0371
Tessa-Virginia HannemannHochschule für Technik und Wirtschaft des Saarlandes (htw saar), Germany.ORCID 0000-0002-0660-0897
Alexander SchumacherSHARE Germany, SHARE Berlin Institute.ORCID 0000-0002-8855-7000
Nikolaos TheodoropoulosDepartment of Economics, University of Cyprus.ORCID 0000-0002-0415-6534

Funding

Enhancing the Comparability of SHARE with HRS and ELSAR01AG052527 · NIA · MAX PLANCK INST/SOCIAL LAW/SOCIAL POLICY · PI BOERSCH-SUPAN, AXEL H · 2016 to 2020
$2.1M
NIA NIH HHS HHSN271201300071CNIA NIH HHS R01 AG052527
6 · The paper itself

Abstract

This study investigates vaccine hesitancy among the 50+ population in Europe and Israel during the COVID-19 pandemic, focusing on the role of national contexts alongside individual determinants. Utilizing data from the SHARE Corona Surveys (SCS1 and SCS2), the analysis includes over 48,000 respondents across 28 countries. The framework is guided by the WHO's Complacency, Convenience, and Confidence (3Cs) model to explore factors influencing vaccination intent. Complacency examines perceived risks and visibility of the virus's consequences, convenience evaluates accessibility and affordability of vaccines, and confidence assesses trust in vaccines, healthcare systems, and policymakers. Key findings suggest that higher COVID-19 mortality rates and stricter containment measures reduce complacency and increase vaccine uptake. Greater healthcare expenditure and Human Development Index (HDI) scores enhance convenience, leading to higher vaccination rates. Additionally, trust in governments and health authorities as well as in the vaccine itself predict confidence, shaping vaccination intent. The study reveals significant national disparities in vaccination attitudes and behaviours, linked to socio-economic factors and healthcare quality. By incorporating multivariate logistic regression models, the research highlights the interplay between individual and national factors, suggesting that successful vaccination campaigns require a holistic approach addressing both personal hesitations and systemic barriers. This research hence underscores the importance of public trust, robust healthcare systems, and targeted communication strategies to mitigate vaccine hesitancy and improve pandemic response outcomes.

Indexed as

3C modelcomplacencyconfidenceconvenienceCOVID-19macro indicatorsmulti-levelnational contextSHAREvaccine hesitancyweightingWHO

Identifiers

PMID40832376
PMCPMC12363742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.